Skip to content
Events

Thank you for joining us at the event. The symposium recording is now available - click the button below to watch:

Next Generation Sequencing for dummies. How to implement metagenomics for respiratory infections? Pr. John Rossen
Shotgun metagenomics for clinical samples. Why all laboratories should use it in routine? Dr. Christophe Rodriguez
State of the Art: Next Generation Sequencing & Tuberculosis Dr. Philip Supply
Genomics surveillance SARS-CoV-2 and beyond: experience from Israel Nir Rainy
Metagenomics of the human microbiome: key clinical applications in 2022 Nicola Segata

Watch Now

Details

These are our on-demand presentations from the Illumina Symposium that was held at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) this late April.

Our sponsored workshop brought together leading researchers, discussing how NGS technology can accelerate Clinical Microbiology studies and yield more actionable discoveries, for applications such as clinical metagenomics, surveillance,microbiome analyses, and more.If you are curious to know how genomics can help you detect, identify, and test microbial species, beyond COVID, this might be your jam!

Date & Time
Apr 23, 2022
12:00 PM
Location
N/A
Portugal
Europe
Topic
Complex disease genomics
Watch Now

Related Events

Feb 26
Illumina’s Integrated Workflow for Rare and Undiagnosed Genetic Disease Research
Feb 26, 2025
Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.